SANUWAVE Health, Inc.
SNWV
$18.61
-$0.24-1.27%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 26.81% | 22.34% | 41.92% | 61.46% | 47.64% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 26.81% | 22.34% | 41.92% | 61.46% | 47.64% |
| Cost of Revenue | 48.45% | 10.16% | 14.78% | 23.61% | 5.84% |
| Gross Profit | 20.66% | 26.29% | 51.87% | 75.73% | 66.31% |
| SG&A Expenses | 21.99% | 45.17% | 98.85% | 22.23% | 93.79% |
| Depreciation & Amortization | 32.13% | 7.77% | -3.33% | 5.49% | 16.93% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 33.14% | 34.79% | 60.29% | 22.24% | 57.40% |
| Operating Income | -35.47% | -24.88% | -5.77% | 193.90% | -8.28% |
| Income Before Tax | 142.93% | 149.98% | -83.92% | -25.35% | -179.13% |
| Income Tax Expenses | 218.52% | -- | -- | -- | 575.00% |
| Earnings from Continuing Operations | 142.25% | 149.98% | -83.92% | -25.35% | -179.29% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 142.25% | 149.98% | -83.92% | -25.35% | -179.29% |
| EBIT | -35.47% | -24.88% | -5.77% | 193.90% | -8.28% |
| EBITDA | -18.45% | -19.58% | -8.58% | 230.74% | -9.01% |
| EPS Basic | 141.46% | 118.58% | -94.08% | 54.55% | -128.26% |
| Normalized Basic EPS | 133.67% | 110.79% | -68.95% | 53.47% | -135.28% |
| EPS Diluted | 101.25% | 107.13% | -99.60% | 54.55% | -128.26% |
| Normalized Diluted EPS | 132.82% | 110.12% | -65.97% | 53.47% | -135.28% |
| Average Basic Shares Outstanding | 1.90% | 169.07% | 171.58% | 175.79% | 180.57% |
| Average Diluted Shares Outstanding | 4.54% | 186.95% | 147.81% | 175.79% | 180.57% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |